Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Nilotinib can cause skin issues like red bumps and hair loss.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Switching to a twice-weekly betamethasone treatment led to full hair regrowth in alopecia areata without side effects.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

The woman has Discoid Lupus Erythematosus and needs specialist care.

Treat active lichen planopilaris early to prevent permanent hair loss.

Light therapy using helium-neon lasers can help restore skin color in vitiligo by promoting skin cell growth and movement.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The rash resolved after stopping ponatinib.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Surgical treatments and topical tofacitinib may help with vitiligo-related eyebrow and eyelash whitening, but more research is needed.

PRP treatment improved skin pigmentation and appearance in facial lichen planus pigmentosus.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Peficitinib can turn human fibroblasts into cells that help grow hair.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.